title: Objective response to sorafenib in advanced clear-cell sarcoma.
authors.affiliation: Sarcoma Unit, Cochin Teaching Hospital, Université Paris Descartes, Sorbonne Paris Cité, AP-HP, Paris, France. Electronic address: olivier.mir@cch.aphp.fr.
authors.forename: O
authors.initials: O
authors.lastname: Mir
authors.affiliation: Sarcoma Unit, Cochin Teaching Hospital, Université Paris Descartes, Sorbonne Paris Cité, AP-HP, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Boudou-Rouquette
authors.affiliation: Sarcoma Unit, Cochin Teaching Hospital, Université Paris Descartes, Sorbonne Paris Cité, AP-HP, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Larousserie
authors.affiliation: Sarcoma Unit, Cochin Teaching Hospital, Université Paris Descartes, Sorbonne Paris Cité, AP-HP, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Babinet
authors.affiliation: Sarcoma Unit, Cochin Teaching Hospital, Université Paris Descartes, Sorbonne Paris Cité, AP-HP, Paris, France.
authors.forename: V
authors.initials: V
authors.lastname: Dumaine
authors.affiliation: Sarcoma Unit, Cochin Teaching Hospital, Université Paris Descartes, Sorbonne Paris Cité, AP-HP, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Anract
authors.affiliation: Sarcoma Unit, Cochin Teaching Hospital, Université Paris Descartes, Sorbonne Paris Cité, AP-HP, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Goldwasser
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D006801:Humans; D007717:Knee / Q000473:pathology*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives; D015514:Oncogene Proteins, Fusion; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use*; D018227:Sarcoma, Clear Cell / Q000188:drug therapy* / Q000235:genetics; D000077157:Sorafenib; D014157:Transcription Factors
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; C111598:EWS-ATF1 fusion protein, human; D015514:Oncogene Proteins, Fusion; D010671:Phenylurea Compounds; D011725:Pyridines; D014157:Transcription Factors; D009536:Niacinamide; D000077157:Sorafenib